Cellular reprogramming for understanding and treating human disease
نویسندگان
چکیده
منابع مشابه
Cellular reprogramming for understanding and treating human disease
In the last two decades we have witnessed a paradigm shift in our understanding of cells so radical that it has rewritten the rules of biology. The study of cellular reprogramming has gone from little more than a hypothesis, to applied bioengineering, with the creation of a variety of important cell types. By way of metaphor, we can compare the discovery of reprogramming with the archeological ...
متن کاملNeural Circuit Reprogramming: A New Paradigm for Treating Neuropsychiatric Disease?
Theoretically, harnessing the brain's own endogenous plasticity mechanisms could serve to alter both internal states and external behavior in a therapeutic manner.
متن کاملPotential Vaccines for Treating Crohn\'s Disease
Crohn's disease (CD) is an inflammatory disease of the gastrointestinal tract (GIT) tract and can affect several parts of the digestive system. There is a relationship between impaired mucosal barrier in the GIT of inflammatory bowel disease patients and the role of bacteria such as Mycobacterium avium paratuberculosis in CD. Apart from different therapeutic approaches for treating CD, developm...
متن کاملTreating a Disease vs. Understanding a Disease
which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. Orthopaedic surgical techniques have evolved rapidly over recent decades, and enormous improvements in the clinical outcome have been achieved. Orthopaedic surgeons generally believe that they are top specialists in bone and joint problems. However, I am ske...
متن کاملProgress in understanding and treating Parkinson's disease.
This review evaluates the long-term results of Levodopa therapy in Parkinson's disease upon quality of life, prolongation of survival and excess mortality. It also focuses on recent and new therapeutic approaches: Levodopa in combindation with a Dopa-decarboxylase inhibitor or MAO-B inhibitor, dopamine agonists and an active tripeptide: L-prolyl-L-leucylglycine amide (MIF-I). It ends by looking...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Frontiers in Cell and Developmental Biology
سال: 2014
ISSN: 2296-634X
DOI: 10.3389/fcell.2014.00067